Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,279 results for "Medical Malpractice Law & Strategy"...

Document Exchange Breaches
November 26, 2013
What would happen if a clien'ts information was breached or hacked? It is an alarming possibility and one that should rightfully occupy your thoughts.
The Pitfalls of an Overly Qualified Expert Witness
November 26, 2013
Who is qualified to offer opinions as to what deviation from the standard of care for a general practitioner would be?
The Media
October 31, 2013
While the media creates the impression of an out-of-control tort system, this is out of alignment with actual jury behavior.
Verdicts
October 30, 2013
In-depth analysis of a recent key ruling.
Med Mal News
October 30, 2013
Is there such a thing as "publishing malpractice"? A look at a recent court ruling.
Drug & Device News
October 30, 2013
Analysis of two important news items.
When Med Mal and Mass Tort Claims Overlap
October 30, 2013
Med Mal defense attorneys must also be aware of the potential overlap between malpractice claims and mass tort claims.
NJ's Offer of Judgment Rule
October 30, 2013
The Offer of Judgment Rule (the Rule) is a near universal concept that exists in most jurisdictions. Its However, in its current application, at least in New Jersey, it is ineffectual and pragmatically only available to plaintiffs.
In-Hospital Falls
October 30, 2013
According to the Centers for Disease Control and Prevention (CDC), each year one in every three "older adults" (65 years and older) falls. According to the CDC's report, in 2010, approximately 21,000 older adults died from unintentional fall injuries. The most common fall-related injuries were fractures of the spine, hip, forearm, leg, ankle, pelvis, upper arm, and hand.
Med Mal News
September 25, 2013
In-depth review of key news items.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›